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1. Materials, DNA isolation and manipulation 
Restriction endonucleases and Taq ligase were obtained from New England BioLabs. Phusion DNA 
polymerase was purchased from Thermo Scientific. T5 exonuclease was purchased from Epicentre. 
T4DNA ligase, alkaline phosphatase and protease inhibitors were purchased from Roche. All other 
chemicals were from Sigma-Aldrich. 
All constructs were cloned from the MLSA1 or MLSB genes using either transfer polymerase chain 
reactions [Erijman et al., 2011; Erijman et al., 2014] or Gibson assembly [Gibson et al., 2009] and the 
primers described in Table S1. The products were treated with DpnI for 2 h at 37 °C and transformed 
into competent E. coli DH5α cells (Life Technologies) prior to conducting colony polymerase chain 
reactions using the method of Nybo [Nybo, 2012] to filter out false positive colonies. Plasmid DNA was 
isolated from an overnight culture using a Wizard Mini-prep set (Promega). Final confirmation of 
cloning steps was obtained by DNA sequencing (DNA Sequencing Facility, Department of Biochemistry, 
University of Cambridge). 
 
2. Protein expression and purification of KR domain samples 
mKRa 
The sequence coding for mKRa in module 5 of the mlsA1 gene from Mycobacterium ulcerans (Uniprot: 
Q6MZA4; residues 10604-11078; Table S2) was cloned using the primers into pVB, a modified pET28α 
vector in which the amino acid recognition sequence for thrombin had been replaced with that for 
tobacco etch virus (TEV) protease, preceeded by an N-terminal His6-tag fused to GB1, the 56-residue 
B1 immunoglobulin binding domain of Streptococcal protein G [Bao et al., 2006]. The pVB-mKRa 
plasmid was transformed into competent E. coli Tuner (DE3) cells (Merck). The His6-GB1-mKRa fusion 
protein was expressed by growing the cells at 37 °C in 1 L of LB medium, prepared according to 
standard protocols [Sambrook & Russell, 2001], with 30 μg/mL kanamycin (Sigma) for selection, to a 
600 nm optical density of 0.8, followed by induction with 0.5 mM isopropyl β-D-1-thiogalacto-
pyranoside (IPTG; Sigma) and incubation at 20 °C for 20 h. Cells were harvested by centrifugation 
(20 min; 3583 x g), resuspended in lysis buffer (50 mM Na2HPO4, 300 mM NaCl, pH 8.0) with 5 mM 
imidazole, 2.5 units/mL benzonase nuclease (EMD Millipore) and Sigmafast EDTA-free protease 
inhibitor cocktail (Sigma) and then lysed using an Emulsiflex C5 homogeniser (Glen Creston). The 
clarified lysate was passed through Ni-NTA resin (Qiagen), washed twice with lysis buffer containing 
30 mM imidazole and eluted with a buffer containing 50 mM Na2HPO4, 300 mM NaCl, 300 mM 
imidazole, 0.01 % (v/v) NaN3, pH 8.0. The eluted protein was exchanged into phosphate buffer (50 mM 
Na2HPO4, 150 mM NaCl, 0.01 % (v/v) NaN3, pH 7.5) and the His6-GB1-tag was cleaved by overnight 
incubation at 4 °C with 100 μL N-terminally His6-tagged TEV protease in 1 mL TEV buffer (1 M Na2HPO4, 
10 mM EDTA, 20 mM DTT, pH 7.5). The released His6-GB1-tag was removed by passing the sample 
through Ni-NTA resin (Qiagen). The resin was flushed with a buffer containing 50 mM Na2HPO4, 
300 mM NaCl, 5 mM imidazole, 0.01 % (v/v) NaN3, pH 8.0 and then washed with 50 mM Na2HPO4, 
300 mM NaCl, 30 mM imidazole, 0.01 % (v/v) NaN3, pH 8.0; all the protein flow through was collected. 
The His6-tagged GB1 and TEV protease were eluted using a buffer containing 50 mM Na2HPO4, 
300 mM NaCl, 30 mM imidazole, 0.01 % (v/v) NaN3, pH 8.0. The mKRa in the flow through was further 
purified by size exclusion chromatography using an Äkta Purifier 10 system equipped with a Superdex 
75 10/300 column (GE Healthcare) in a buffer containing 25 mM HEPES, 50 mM NaCl. The mKRa 
sample was concentrated using 5000 MWCO Vivaspin 20 columns (Sartorius Stedim) and stored at 
4 °C. All expression and purification steps were monitored by SDS-PAGE (NuPAGE) 4-12 % Bis-Tris gels 
(Life Technologies) stained with InstantBlue (Expedeon) (Figure S2). 
mKRb 
The sequence coding for mKRb in module 7 of the mlsB gene from Mycobacterium ulcerans (Uniprot: 
Q32YM8; residues 13784-13874; Table S2) was cloned into pVB and the resulting pVB-mKRb plasmid 
was transformed into competent E. coli Tuner (DE3) cells (Merck). The His6-GB1-mKRb fusion protein 
was expressed and the released mKRb product was purified using the same protocol described above 
for mKRa. All expression and purification steps were monitored by SDS-PAGE (NuPAGE) 4-12 % Bis-
Tris gels (Life Technologies) stained with InstantBlue (Expedeon) (Figure S1). 
 
3. Protein expression and purification of apo ACP samples 
mACPa 
The sequence coding for mACPa in module 5 of the MLSA1 gene from Mycobacterium ulcerans 
(Uniprot: Q6MZA4; residues 11087-11185; Table S2) was cloned into pVH, a modified pET28α vector 
in which the recognition sequence for thrombin had been replaced with that for tobacco etch virus 
(TEV) protease. The pVH-mACPa plasmid was transformed into competent E. coli Tuner (DE3) cells 
(Merck) and N-terminally His6-tagged mACPa protein was expressed by growing the cells at 37 °C in 
1 L of LB medium, prepared according to standard protocols [Sambrook & Russell, 2001], with 
30 μg/mL kanamycin (Sigma) for selection, to a 600 nm optical density of 0.8, followed by induction 
with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG; Sigma) and incubation at 15 °C for 16 h. 
Cells were harvested by centrifugation (20 min; 3583 x g), resuspended in lysis buffer (50 mM 
Na2HPO4, 300 mM NaCl, pH 8.0) with 5 mM imidazole, 2.5 units/mL benzonase nuclease (EMD 
Millipore) and Sigmafast EDTA-free protease inhibitor cocktail (Sigma) and lysed using an Emulsiflex 
C5 homogeniser (Glen Creston). The clarified lysate was passed through Ni-NTA resin (Qiagen), 
washed twice with lysis buffer containing 30 mM imidazole and eluted with lysis buffer containing 
(50 mM Na2HPO4, 300 mM NaCl, 300 mM imidazole, 0.01 % (v/v) NaN3, pH 8.0). The eluted protein 
was exchanged into phosphate buffer (50 mM Na2HPO4, 150 mM NaCl, pH 7.5) and the His6-tag was 
cleaved by overnight incubation at 4 °C with TEV protease in 1 mL TEV buffer (1 M sodium phosphate, 
10 mM EDTA, 20 mM DTT, pH 7.5). The released mACPa was further purified by size exclusion 
chromatography using an Äkta Purifier 10 system equipped with a Superdex 75 10/300 column (GE 
Healthcare) in phosphate buffer. The sample was concentrated using 5000 MWCO Vivaspin 20 
columns (Sartorius Stedim). All expression and purification steps were monitored by SDS-PAGE 
(NuPAGE) 4-12 % Bis-Tris gels (Life Technologies) stained with InstantBlue (Expedeon) (Figure S2). The 
identity of the sample was confirmed by electrospray injection mass spectrometry (ESI-MS; PNAC 
facility, Department of Biochemistry, University of Cambridge; Table S3 and Figure S3). 
mACPb 
The amino acid sequence for mACPb coded in module 7 of the MLSB gene from Mycobacterium 
ulcerans (Uniprot: Q32YM8; residues 13784-13874; Table S2) is identical to that of the ACP domain 
(mACP9) coded by the MLSA2 gene (Uniprot: Q6MZA5; residues 2050-2140) studied previously by 
Vance and coworkers [Vance et al., 2016]. As described in that paper, a pET28α vector was used to 
express N-terminally His6-tagged mACPb in E. coli Tuner (DE3) cells (Merck). The cells were grown at 
37 °C in 1 L of LB medium, prepared according to standard protocols [Sambrook & Russell, 2001], with 
30 μg/mL kanamycin (Sigma) for selection, to a 600 nm optical density of 0.8, followed by induction 
with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG; Sigma) and incubation at 15 °C for 16 h. 
The cells were harvested and mACPb was purified and concentrated as described above for mACPa, 
except His6-tag cleavage was performed using restriction grade thrombin (EMD Millipore). All 
expression and purification steps were monitored by SDS-PAGE (NuPAGE) 4-12 % Bis-Tris gels (Life 
Technologies) stained with InstantBlue (Expedeon) (Figure S2) and the identity of the sample was 
confirmed by ESI-MS (PNAC facility, Department of Biochemistry, University of Cambridge; Table S3 
and Figure S3). 
 
4. Validation of KR domain secondary structure and reductase activity 
Despite extensive trials, purified samples of mKRa and mKRb proved to be unsuitable for analysis by 
mass spectrometry using the Waters Q-TOF micro system in the Protein and Nucleic Acid (PNAC) 
Facility, Department of Biochemistry, University of Cambridge, due to aggregation during the injection 
step. To validate these samples, we confirmed that the enzyme domains possessed secondary 
structure using circular dichroism (CD) spectroscopy and displayed NADPH-dependent reductase 
activity against trans-1-decalone using a previously established assay [Siskos et al., 2005]. 
For CD spectroscopy, protein samples were prepared at 0.2 mg/mL in phosphate buffer (45 mM 
Na2HPO4, 5 mM NaH2PO4, 150 mM NaF, 0.01 % (v/v) NaN3, pH 7.5). Molar ellipticity data, [θ], was 
collected at 30 °C using an Aviv model 410 circular dichroism spectrometer between 200 and 260 nm. 
Runs acquired in triplicate were used to calculate the average spectra displayed in Figure S5, which 
indiacte that both mKRa and mKRb contain a significant proportion of α-helical secondary structure. 
For comparison, the X-ray structure of the KR domain from module 1 of the erythromycin polyketide 
synthase (PDB code, 2FR0) possesses an α-helix content of 37% [Keatinge-Clay & Stroud, 2006]. 
KR domain activities were assessed using a previously designed assay by incubation at 30 °C with 
NADPH and the substrate mimic trans-1-decalone (TDL) in HEPES buffer (25 mM HEPES, 50 mM NaCl, 
pH 7.5) at 30 °C. Assay reactions were set up in a Costar 96 well UV-transparent plate (Corning) and 
the progress of the reaction was followed for 20 min by monitoring the depletion of NADPH at 340 nm 
at 20 s intervals using a Spectramax Plus microplate reader running Softmax Pro (Molecular Devices) 
with 2 s shaking in between reads. The final assay volume was 110 μL, yielding NADPH and KR domain 
concentrations of 1.3 mM and 8 μM, respectively. The KR domain was incubated with NADPH for 
20 min prior to addition of TDL. TDL was dissolved in 3 % (v/v) DMSO and its initial well concentration 
was varied from 0 to 50 mM, while the total amount of DMSO in the well was kept constant. Assays 
were performed in triplicate for each run to generate plots of the initial rate of consumption of NADPH 
(v0) against TDL concentration. Fitting to the Michaelis-Menten equation, v0 = Vmax[TDL]/(KM + [TDL]), 
using SoftmaxPro v6 yielded values for Vmax, kcat and KM, as displayed in Table S4. These results confirm 
that the KR domain constructs prepared for this work possess kinetic parameters very similar to those 
obtained in previous studies [Bali & Weissman, 2006]. 
Overall, since both mKRa and mKRb contain appropriate secondary structure and show activities 
similar to those of previously studied equivalents, we concluded that our samples are likely to possess 
native tertiary structure. 
 
5. Preparation of holo and acyl-loaded ACP samples 
ACP constructs were prepared in the Ppant-attached holo form in vivo by co-expression. Two 
expression vectors, one coding for the ACP construct (pVH-mACPa or pET28α-mACPb) and the other 
coding for the broad specificity phosphopantetheinyl transferase Sfp (pET-Sfp) [Quadri et al., 1998], 
were co-transformed into E. coli Tuner(DE3) cells. Procedures for the expression and purification of 
the holo ACP species were as described for the apo species in Section 3 above. The modification state 
of the ACP domain was confirmed by ESI-MS (PNAC facility, Department of Biochemistry, University 
of Cambridge; Table S3 and Figure S3). 
Loading reactions for acyl-ACP species were set up in vitro. An apo ACP sample (0.1 mM) was 
incubated at 27 °C for 2 h with Sfp (4.4 mM) and either acetoacetyl-CoA (2 mM) or β-hydroxybutyryl-
CoA (2 mM) in phosphate buffer (45 mM Na2HPO4, 5 mM NaH2PO4, 150 mM NaCl, 0.01 % (v/v) NaN3, 
pH 7.5) supplemented with 10 mM MgCl2. To separate the loaded protein from Sfp and any excess 
substrate, the mixture was purified by size exclusion chromatography, as described in Section 3 above. 
The identity of the eluted protein was confirmed by ESI-MS (PNAC facility, Department of 
Biochemistry, University of Cambridge; Table S3 and Figure S4). For acyl-ACP samples, ESI-MS analysis 
was carried out after conducting the ITC experiments described in Section 6 below. Although the 
samples were stored at 4 °C during this 24 h period, both of the acetoacetyl-ACP species proved to be 
mildly unstable: their mass spectra in panels A and B of Figure S3 show minor species that result from 
hydrolysis to the holo ACP form. However, the absence of signals from the starting material (apo ACP 
species) indicate that in both cases the loading reaction had run to completion. By contrast, no 
hydrolysis was observed for the two β-hydroxybutyryl-ACP species (panels C and D of Figure S3). 
 
6. Isothermal titration calorimetry experiments 
ITC measurements of affinity (KD), stoichiometry (n) and apparent enthalpy change (ΔH°) were 
obtained using a VP-ITC microcalorimeter (MicroCal Inc.). Samples for the cell and injectant solutions 
were prepared in the same buffer (25 mM HEPES, 50 mM NaCl, 0.01 % (v/v) NaN3, pH 7.5). Small 
compounds of interest were dissolved in the flow through from the 5 kDa MWCO Sartorius centrifugal 
concentrators used to prepare each KR domain sample, to ensure that the buffers were closely 
matched. All samples were degassed under vacuum using a ThermoVac accessory (MicroCal Inc.) and 
loaded into the cell and the syringe. The same protocol was used for all experiments, which were 
conducted at 30 °C with a stirring speed of 300 rpm and a sequence of 29 injections of 10 μL, each 
lasting 7.1 s, and with a 240 s interval between each injection. The first injection was set to a smaller 
volume (2 μL in 3.3 s) to allow the cell and needle solutions to mix, and the resulting heat change was 
disregarded in the later analysis. Control experiments were run to confirm that dilution heat changes 
caused by the titration of injectant into the cell solution were negligible. Dilution heat change 
thermograms for each cell sample were subtracted from the final trace before integration with respect 
to time to generate an isotherm trace. All isotherm traces were analysed using ORIGIN, version 7.0 
(MicroCal, Inc.) with a model that assumed a single binding site. The resulting KD values were averaged 
across 3 technical replicates and a standard deviation was calculated. Representative ITC 
thermograms and isotherm plots for experiments with KR samples in the cell and either ACP species 
or Ppant fragments in the syringe are displayed in Figures S6, S7, S8 and S9. 
Interestingly, the heat changes observed on titration of either apo mACPa or apo mACPb against their 
cognate KR domains in the absence of NADPH or NADP+ were miniscule (data not shown); at 
± 0.1 μcal s-1 per injection, these responses were little different from those observed in dilution 
control experiments (see Fig. 2 of the main text). The lack of a strong heat change signature in the 
absence of cofactor indicates that binding is weak or non-existent, or that the interaction between 
the injectant and its binding partner must be isothermic under the conditions of the experiment. 
Furthermore, in the absence of cofactor titration of holo or acyl-ACP species, or of any of the 
prosthetic group fragments detailed in Scheme 2 of the main text, against either of the KR domains 
again produced thermograms that resembled dilution control experiments (data not shown). Finally, 
titration of NADPH or NADP+ against either of the KR domains yielded similarly weak heat changes 
(data not shown). Since there is no doubt that the cofactor must bind to the enzyme so that 
ketoreduction can occur, we conclude that these interactions must be isothermic under the 
experimental conditions employed here.  
 
  
Table S1: Oligonucleotide primers 
PCR primers used for cloning the mycolactone polyketide synthase KR and ACP constructs. 
Target Direction DNA sequence (5’ to 3’) 
mKRa F AGCAGCGGCGAAAACCTGTATTTTCAGGGCCGCGCGGAGCGCA 
 R GCCAACTCAGCTTCCTTTCGGGCTTTGTTAGCGGTAAGCCATTACCTCTGTG 
mKRb F AGCAGCGGCGAAAACCTGTATTTTCAGGGCGACTCATTGATCACCCGCCCC 
 R ACCACACCACGGCGCCGGTAACAAAGCCCGAAAGGAAGCTGAGTTGGC 
mACPa F AGCAGCGGCGAAAACCTGTATTTTCAGGGCTCGACGGCGACGCTCC 
 R GCCAACTCAGCTTCCTTTCGGGCTTTGTTAACCGATGCCAGGGATCTGTTC 
mACPb F AGCAGCGGCGAAAACCTGTATTTTCAGGCGCCTCAACGGACTTAGC 
 R GCCAACTCAGCTTCCTTTCGGGCTTTGTTAATGGCTTTGGGTGAGTCG 
 
 
Table S2: Amino acid sequences of protein constructs 
Amino acid sequences of the mycolactone polyketide synthase KR and ACP constructs. 
Construct Amino acid sequence (N-terminal to C-terminal) 
mKRa  GRAERTQSEL DSWRYQVTWL SSPATPSSIT LSGIWLLIVP SELAKTDPVI 
GCAAALEAHG ALVTIITIFE PDFNRSLMGA SLKDIGSHIS GVISFLGIHG 
SEFSDSGAVK TLNLVQAMGD VHLDVPLWCL TQGAVSISAD DLIRCSSAAL 
VWGLGRVVAL EHPGSWGGLV DLPESPDDAA WERLCALLAQ PTDEDQFAIR 
PSGVFLRRLI HAPATTTSKS STAWAPRGTV LITGGTGALG AHVARWLAHK 
YESVDLLLTS RRGMAADGAT ELVDDLRTAG ASVTVHACDV TDRTSVEAAI 
AGKSLDAVFH LAGRHQPTLL TELEDESFSD ELAPKVHGAQ VLSDITSNLT 
LSAFVMFSSV AGIWGGKSQG AYAAANAFLD SLAEKRRTLG LPATSVAWGL 
WAGGGMGDRP SASGLNLIGL KSMSADLAVQ ALSDAIDRPQ ATLTVASVNW 
DRFYPTFALA RPRPFLHEIT EVMAYR  
mKRb  GDSLITRPLT TATGSAPATT AAGLLHLSWP PHPDTTTDTD TDTDALRYQV 
IAEPTQQLPR YLHDLHTSTD LHTSTTEADV VVWPVPVPSN EELQAHQASD 
TAVSSRIHTL TRQTLTVVQD WLTHPDTTGT RLVIVTRHGV STSAHDPVPD 
LAHAAVWGLI RSAQNEHPGR FTLLDTDDNT NSDTLTTALT LPTRENQLAI 
RRDTIHIPRL TRHSSDGALT APVVVDPEGT VLITGGTGTL GALFAEHLVS 
AHGVRHLLLT SRRGPQAHGA TDLQQRLTDL GAHVTITACD ISDPEALAAL 
VNSVPTQHRL TAVVHTAAVL ADTPVTELTG DQLDQVLAPK IDAAWQLHQL 
TYEHNLSAFI MFSSMAGMIG SPGQGNYAAA NTALDALADY RHRLGLPATS 
LAWGYWQTHT GLTAHLTDVD LARMTRLGLM PIATSHGLAL FDAALATGQP 
VSIPAPINTH TLARHARDNT LAPILSALIT TPRRR  
mACPa  GSTATLLTSK LAGLTATEQR AVTRKLVLDQ AASVLGYAST ESLDTHESFK 
DLGFDSLTAL ELRDHLQTAT GLNLSSTLIF DHPTPHAVAE HLLEQIPGIG  
mACPb  GSHMRLNGLS PQQQQQTLAT LVAAATATVL GHHTPESISP ATAFKDLGID 
SLTALELRNT LTHNTGLDLP PTLIFDHPTP HALTQHLHTR LTQSH  
 
  
Table S3: ESI-MS analysis of ACP species 
Predicted and experimental molecular masses for ACP species determined by ESI-MS. 
ACP species Predicted mass             
/ Da 
Experimental mass     
/ Da 
apo mACPa 10596.1 10598.0 
holo mACPa 10937.2 10937.3 
acetoacetyl-mACPa 11021.2 11021.3 
β-hydroxybutyryl-mACPa 11023.2 11023.2 
apo mACPb 10224.5 10224.8 
holo mACPb 10564.8 10564.8 
acetoacetyl-mACPb 10648.8 10649.6 
β-hydroxybutyryl-mACPb 10650.8 10650.8 
 
 
Table S4: Kinetic parameters for KR domain constructs 
Comparison of kinetic parameters determined for mycolactone KR domain species in the current work 
with those obtained previously [Bali & Weissman, 2006]. Data shows values for the mean and the 
standard deviation obtained from three technical replicate experiments. 
KR species KM  /  mM kcat  /  s –1 kcat / KM  /  s –1 M –1 
mKRa (current work) 3.0 (± 0.4) 0.20 (± 0.002) 66 (± 22) 
mKRa (previous) 3.2 (± 0.5) 0.28 (± 0.01) 88 (± 17) 
mKRb (current work) 3.1 (± 0.7) 0.40 (± 0.01) 129 (± 14) 
mKRb (previous) 3.7 (± 0.4) 0.52 (± 0.02) 140 (± 20) 
 
  
Figure S1: Module organization for the mycolactone PKS system 
Module organization for the three subunits of the mycolactone PKS system (MLSA1, MLSA2 and MLSB) 
[Stinear et al., 2004]. The structure of mycolactone is colour coded to match the subunits responsible 
for synthesizing each segment. A1-and B1-type KR domains are represented in white and magenta, 
respectively. DH domains that are predicted to be inactive are marked with diagonal black lines. 
Domain abbreviations: KS, ketosynthase; AT, acyltransferase; KR, ketoreductase; DH, dehydratase; ER, 
enoyl reductase; CP, acyl carrier protein; TE, thioesterase. 
 
 
.  
Figure S2: SDS-PAGE analysis 
Each panel displays a 4-12 % Bis-Tris gel containing Thermo Scientific PageRuler prestrained protein 
ladder (left lane) and the indicated protein construct after purification by size exclusion 
chromatography (right lane). 
 
 
 
 
  
Figure S3: ESI-MS spectra of apo and holo ACP species   
Deconvoluted electrospray mass spectra for samples of: (A) apo mACPa; (B) apo mACPb; (C) holo 
mACPa; and (D) holo mACPb. 
 
 
 
 
  
Figure S4: ESI-MS spectra of acyl-ACP species 
Deconvoluted electrospray mass spectra for samples of: (A) acetoacetyl-mACPa; (B) acetoacetyl-
mACPb; (C) β-hydroxybutyryl-mACPa; and (D) β-hydroxy-butyryl-mACPb. 
 
 
 
 
  
Figure S5: Circular dichroism spectra of KR domain constructs 
CD spectra are displayed for samples of (A) mKRa and (B) mKRb, both showing minima at 209 nm and 
222 nm, which are characteristic α-helical secondary structure. 
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Figure S6: Isothermal titration calorimetry data I 
Representative ITC thermograms (upper panels) and isotherm plots (lower panels), all in the presence 
of excess NADPH, showing consecutive injections of: (A) apo mACPa against mKRb; (B) apo mACPb 
against mKRa; (C) holo mACPa against mKRa; (D) holo mACPb against mKRb; (E) β-hydroxybutyryl-
mACPa against mKRa; and (F) β-hydroxybutyryl-mACPb against mKRb. Thermogram traces for dilution 
control experiments are shown at the top of each upper panel. 
 
  
Figure S7: Isothermal titration calorimetry data II 
Representative ITC thermograms (upper panels) and isotherm plots (lower panels), all in the presence 
of excess NADP+, showing consecutive injections of: (A) apo mACPa against mKRa; (B) apo mACPb 
against mKRb; (C) holo mACPa against mKRa; (D) holo mACPb against mKRb; (E) acetoacetyl-mACPa 
against mKRa; and (F) acetoacetyl-mACPb against mKRb. Thermogram traces for dilution control 
experiments are shown at the top of each upper panel. 
 
  
Figure S8: Isothermal titration calorimetry data III 
Representative ITC thermograms (upper panels) and isotherm plots (lower panels), all in the presence 
of excess NADPH, showing consecutive injections of: (A) R-pantetheine against mKRa; (B) R-pante-
theine against mKRb; (C) pantoate against mKRa; (D) pantoate against mKRb; (E) β-alanine against 
mKRa; (F) β-alanine against mKRb; (G) N-acetyl cysteamine against mKRa; (H) N-acetyl cysteamine 
against mKRb; and (I) cysteamine against mKRb. Thermogram traces for dilution control experiments 
are shown at the top of each upper panel. 
  
Figure S9: Isothermal titration calorimetry data IV 
Representative ITC thermograms (upper panels) and isotherm plots (lower panels), all in the presence 
of excess NADP+, showing consecutive injections of: (A) R-pantetheine against mKRa; (B) R-pante-
theine against mKRb; (C) pantoate against mKRa; (D) pantoate against mKRb; (E) β-alanine against 
mKRa; (F) β-alanine against mKRb; (G) N-acetyl cysteamine against mKRa; (H) N-acetyl cysteamine 
against mKRb; and (I) cysteamine against mKRb. Thermogram traces for dilution control experiments 
are shown at the top of each upper panel. 
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